[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants

J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - Elsevier
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …

Pharmacokinetics of veterinary drugs in laying hens and residues in eggs: a review of the literature

V Goetting, KA Lee, LA Tell - Journal of veterinary …, 2011 - Wiley Online Library
Goetting, V., Lee, KA, Tell, LA Pharmacokinetics of veterinary drugs in laying hens and
residues in eggs: a review of the literature. J. vet. Pharmacol. Therap. 34, 521–556. Poultry …

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug

L Jia, JE Tomaszewski, C Hanrahan… - British journal of …, 2005 - Wiley Online Library
1 SQ109 is a novel [1, 2]‐diamine‐based ethambutol (EMB) analog developed from high‐
throughput combinatorial screening. The present study aimed at characterizing its …

[HTML][HTML] Downregulation of nutrition sensor GCN2 in macrophages contributes to poor wound healing in diabetes

Y Hou, D Wei, Z Zhang, T Lei, S Li, J Bao, H Guo, L Tan… - Cell Reports, 2024 - cell.com
Poor skin wound healing, which is common in patients with diabetes, is related to
imbalanced macrophage polarization. Here, we find that nutrition sensor GCN2 (general …

Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

MJA De Jonge, H Dumez, J Verweij, S Yarkoni… - European journal of …, 2006 - Elsevier
PURPOSE: Halofuginone (tempostatin™) is a synthetic derivative of a quinazolinone
alkaloid showing anti-angiogenic, anti-metastatic and anti-proliferative effects in preclinical …

Halofuginone, a promising drug for treatment of pulmonary hypertension

PP Jain, T Zhao, M Xiong, S Song, N Lai… - British journal of …, 2021 - Wiley Online Library
Background and Purpose Halofuginone is a febrifugine derivative originally isolated from
Chinese traditional herb Chang Shan that exhibits anti‐hypertrophic, anti‐fibrotic and anti …

The role of halofuginone in fibrosis: more to be explored?

Y Luo, X Xie, D Luo, Y Wang… - Journal of Leukocyte …, 2017 - academic.oup.com
Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular
matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction …

The prolyl-tRNA synthetase inhibitor halofuginone inhibits SARS-CoV-2 infection

DR Sandoval, TM Clausen, C Nora, AP Cribbs… - bioRxiv, 2021 - biorxiv.org
We identify the prolyl-tRNA synthetase (PRS) inhibitor halofuginone, a compound in clinical
trials for anti-fibrotic and anti-inflammatory applications, as a potent inhibitor of SARS-CoV-2 …

A novel inhibitor of Smad‐dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis

M Hasegawa, Y Matsushita, M Horikawa… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Tissue fibrosis is a major cause of morbidity and mortality in systemic sclerosis
(SSc), and an increasing number of promising molecular targets for antifibrotic therapies …

Activation of the amino acid response pathway blunts the effects of cardiac stress

P Qin, P Arabacilar, RE Bernard, W Bao… - Journal of the …, 2017 - Am Heart Assoc
Background The amino acid response (AAR) is an evolutionarily conserved protective
mechanism activated by amino acid deficiency through a key kinase, general control …